meRfi®-GM
Cardiometabolic Disease (CMD)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The term includes cardiovascular diseases (such as heart disease, heart attack, heart failure, stroke, and vascular disease), Diabetes / Diabetes mellitus, chronic kidney disease (CKD), and non-alcoholic fatty liver disease (NAFLD), including its more severe form, [non-alcoholic steatohepatitis (NASH)](brain://GiE_VzTZS0mh705QAweeOQ/NonAlcoholicS…
References (Sources)
- Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
- Pathogenesis and pathophysiology of the cardiometabolic syndrome
- Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories
- Projections of global mortality and burden of disease from 2002 to 2030
- The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic diseaseReview